(Q42932776)

11 November 2017

The differences of asymmetric dimethylarginine removal by different dialysis treatments (English)

1 reference

11 November 2017

0 references

Dong-Liang Zhang

1

1 reference

11 November 2017

Jing Liu

2

1 reference

11 November 2017

Sha Liu

3

1 reference

11 November 2017

Yu Zhang

4

1 reference

11 November 2017

Wen-Hu Liu

5

1 reference

11 November 2017

1 January 2010

1 reference

11 November 2017

1 reference

11 November 2017

32

1 reference

11 November 2017

8

1 reference

11 November 2017

935-940

1 reference

Impaired endothelial function in isolated human uremic resistance arteries

11 November 2017

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2010.502281

Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in patients with chronic kidney diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2010.502281

Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2010.502281

Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2010.502281

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2010.502281

Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2010.502281

Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2010.502281

Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2010.502281

Dimethylarginines in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2010.502281

ADMA: a novel risk factor that explains excess cardiovascular event rate in patients with end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2010.502281

Asymmetrical dimethylarginine plasma clearance persists after acute total nephrectomy in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2010.502281

The relationship among asymmetric dimethylarginine (ADMA) levels, residual renal function, and left ventricular hypertrophy in continuous ambulatory peritoneal dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2010.502281

Hemodialysis and L-arginine, but not D-arginine, correct renal failure-associated endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F0886022X.2010.502281

10.3109/0886022X.2010.502281

21 January 2018

Identifiers

DOI

1 reference

11 November 2017

1 reference